Ultra Nasdaq Biotechnology Proshares Newsroom

AstraZeneca Reports Positive Phase 3 Results for Truqap in Prostate Cancer

Seeking Alpha17:55 ET

Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025

Seeking Alpha15:10 ET

Gilead Acquires Investigational HIV Vaccine From Spanish Biotech Aelix

Seeking Alpha14:11 ET

Looking Into Vertex Pharmaceuticals's Recent Short Interest

Benzinga13:45 ET

S&P 500, Dow Hit Records Right After Open | Live Stock

Kevin TraversNov 25 10:00 ET

Price Over Earnings Overview: Gilead Sciences

BenzingaNov 25 08:15 ET

Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby

Seeking AlphaNov 23 08:26 ET

Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC

Seeking AlphaNov 22 21:25 ET

Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day

Kevin TraversNov 22 16:17 ET

Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters

Seeking AlphaNov 22 15:00 ET

Market Climbs, Bitcoin Close to $100k | Live Stock

Kevin TraversNov 22 11:06 ET

3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer

Seeking AlphaNov 22 10:58 ET

Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735

Seeking AlphaNov 22 10:20 ET

Amneal Gets FDA Approval for Generic Byetta, Resubmits DHE NDA

Seeking AlphaNov 21 17:01 ET

Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today

Kevin TraversNov 21 16:09 ET

Optimism Over Global Healthcare Sector Rises: Jefferies

Seeking AlphaNov 21 13:45 ET

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

BenzingaNov 21 12:47 ET

Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock

Kevin TraversNov 21 10:53 ET

Gilead Sciences Analyst Ratings

BenzingaNov 21 08:10 ET · Ratings

Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207

BenzingaNov 21 08:08 ET · Ratings